These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8758477)

  • 41. In-vitro activity of new cephalosporin (HR 756) and cefazolin.
    Stratford BC
    Lancet; 1978 Sep; 2(8088):528-9. PubMed ID: 79898
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative susceptibility of Pseudomonas aeruginosa to four cephalosporins.
    Van Klingeren B; Van Wijngaarden B; Rutgers A
    J Antimicrob Chemother; 1980 Sep; 6(5):674-6. PubMed ID: 6773922
    [No Abstract]   [Full Text] [Related]  

  • 43. Chemotherapy with cefotaxime: how to avoid selection of Pseudomonas aeruginosa.
    Bauernfeind A; Petermüller C
    J Antimicrob Chemother; 1980 Sep; 6(5):671-2. PubMed ID: 6251021
    [No Abstract]   [Full Text] [Related]  

  • 44. Identification of Pseudomonas aeruginosa with the API-20E system.
    Amato S; Vanik J; Kocka FE
    Can J Microbiol; 1980 Apr; 26(4):554-5. PubMed ID: 6769576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ceftazidime activity on multiresistant salmonella.
    Goossens H; Vanhoof R; Grados O; Dekegel D; Butzler JP
    Lancet; 1982 Oct; 2(8301):769-70. PubMed ID: 6125838
    [No Abstract]   [Full Text] [Related]  

  • 46. A contrivance for bacteriocine typing.
    Bergan T
    Acta Pathol Microbiol Scand; 1968; 72(3):396-400. PubMed ID: 4967984
    [No Abstract]   [Full Text] [Related]  

  • 47. METALLIC SHEEN IN PSEUDOMONAS AERUGINOSA.
    WAHBA AH
    Nature; 1964 Oct; 204():502. PubMed ID: 14232557
    [No Abstract]   [Full Text] [Related]  

  • 48. The influence of inorganic salts on the activity in vitro of oxytetracycline.
    WEINBERG ED
    Antibiot Chemother (Northfield); 1954 Jan; 4(1):35-42. PubMed ID: 24542873
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.
    Watanabe N; Hiruma R; Katsu K
    J Antimicrob Chemother; 1992 Nov; 30(5):633-41. PubMed ID: 1493980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cefepime activity against Pseudomonas aeruginosa: evaluation of Etest and two disc diffusion methods.
    Stes P; Goossens H
    J Antimicrob Chemother; 1996 Oct; 38(4):707-11. PubMed ID: 8937965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the activity of two broad-spectrum cephalosporins tested against 2,299 strains of Pseudomonas aeruginosa isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
    Ramphal R; Hoban DJ; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 Feb; 36(2):125-9. PubMed ID: 10705055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxacillinase-mediated resistance to cefepime and susceptibility to ceftazidime in Pseudomonas aeruginosa.
    Aubert D; Poirel L; Chevalier J; Leotard S; Pages JM; Nordmann P
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1615-20. PubMed ID: 11353602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparison of four methods for the determination of the susceptibility of 47 strains of Pseudomonas aeruginosa to ceftazidime and cefepime: influence of the choice of interpretative criteria].
    Boucaud-Maître Y; Thoinet S
    Pathol Biol (Paris); 1996 May; 44(5):363-6. PubMed ID: 8758477
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.